Scientific excellence with commercial acumen
The global bioeconomy is growing rapidly, as businesses realise the potential of biodesign and biomanufacturing. From novel materials to new medicines, data storage and living sensors, synthetic biology offers exciting new opportunities to sense, organise and process matter efficiently and cleanly – if you have the capability to turn theory into practice.
Using state-of-the-art facilities and techniques, our synthetic biology team fuses expertise in biology, chemistry and engineering to convert research-driven discovery into breakthrough products and services.
Background in biodesign
Our synthetic biology capability has grown organically from our long history in healthcare and life-sciences.
Recognising a new era of rational biodesign for products and processes is emerging, we created our synthetic biology division in 2015.
Antha is a programming language for biology that describes and executes complex protocols, driving massive productivity gains during biodesign.
Working in partnership with Synthace, we offer an end-to-end service to help clients launch Antha in their labs, delivering significant workflow efficiency benefits.
Biodesign is not fully predictive today and still requires extensive phenotypic characterisation and testing.
We designed an ultra-high throughput agar array-based system to measure ratiometric fluorescent signals from a library of transformed organisms and automatically identify the best-performing individual strain.
Interested in joining us?
Tech, tools & facilities
캠브리지 컨설턴트 본사에 위치한 미생물학 연구실에서는 미생물을 유전적으로 변형하고 그 특징을 파악하는 작업이 가능합니다. 캠브리지 컨설턴트의 생물학 연구실 시설은 병원성 계통 취급이 가능한 밀폐 2등급 시설로, 당사의 인하우스 라이브러리 덕분에 신속한 분자 유전자 구성체 설계 및 조립이 가능합니다. 캠브리지 컨설턴트는 특히 헬스케어와 산업 바이오테크에 적용 가능한 생물학적 센서 유기체 생성에 집중하고 있습니다.
SGI BioXP 3200
This system is the world’s first benchtop automated genomic workstation that rapidly synthesizes high-quality, double-stranded DNA fragments and clones into any vector in an overnight run. Its numerous applications include protein production, antibody library generation and cell engineering.